Bavarian Nordic Chikungunya Vaccine Recommended by CDC’s ACIP

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur – stock.adobe.com

The United States Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) has recommended Bavarian Nordic’s recombinant vaccine for the prevention of disease caused by chikungunya virus (1). Bavarian Nordic, which is based in Denmark, reported the recommendation of the virus-like particle (VLP)-based, single-dose injection (brand name Vimkunya) on April 16, 2025.

The recombinant chikungunya vaccine was previously approved by FDA in February 2025 for…